IL17A and tuberculosis: Therefore, in this study, we aimed to determine the role of soluble IL-17 and IL-17-producing cells at three key transition points in the Mtb infection spectrum: (i) after exposure to a TB case but prior to development of latent TB infection, (ii) after development of LTBI but prior to development of active TB disease, and (iii) before and after treatment of active TB disease.